Floatz logo

Dexmedetomidine

Post-Operative Pain, Non-Human Animal

Tanta UniversitySmall moleculePhase 4 / ApprovedActive
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
81/ 100

Competitive context

22 Active assets in the Post-Operative Pain, Non-Human Animal cohort.

Asset / SponsorPhaseRating
Lidocaine
Instituto Mexicano del Seguro Social
Phase 4BBB
ROPIVACAINE
Tianjin Medical University General Hospital
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Tanta University
Phase 4BBB
NEPENTHE
IVO JURISIC
Phase 4BBB
Marcaine
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB

View all 38 →

Same molecule, other indications

Dexmedetomidine is also rated in:

schizophreniform disorderActive
A
Indicative · Phase 4
80 / 100
View asset →
schizoaffective disorderActive
BBB
Indicative · Phase 4
77 / 100
View asset →
neuralgiaActive
BBB
Indicative · Phase 4
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →